Skip to content

Comparison Between Two Exercise Protocols in the Treatment of Rotator Cuff Tendinopathy: randomized clinical trial

Effects of Proprioceptive Neuromuscular Facilitation Exercises in the treatment of Rotator Cuff Tendinopathy: randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-38xfyp5
Enrollment
Unknown
Registered
2024-11-06
Start date
2024-02-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Interventions

This is a randomized controlled clinical study with four arms, unicentric. All groups will consist of 18 (72 in total) participants with shoulder pain symptoms lasting more than 3 weeks who pass the a
E02.779.474

Sponsors

Fundação Universidade Federal de Sergipe
Lead Sponsor
Fundação Universidade Federal de Sergipe
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants of both genders; aged between 18 and 65 years; who have had shoulder pain for at least three months, the pain should be localized in the lateral and proximal region of the superior aspect of the shoulder (corresponding dermatome of the C5 nerve root), and this complaint should be aggravated during the execution of at least 3 out of 5 specific tests for rotator cuff tendinopathy, which are: Neer, Hawkins-Kennedy, Painful Arc, Jobe, and lateral rotation against resistance; participants should not have passive limitations in flexion, abduction, and external rotation movements

Exclusion criteria

Exclusion criteria: Patients with any history of previous shoulder joint injury; radicular symptoms from the cervical spine; generalized pain condition; evidence of complete rotator cuff tear with loss of active shoulder mobility; fractures in adjacent joints (elbow, wrist/hand); participants with a clinical diagnosis of diseases such as rheumatoid arthritis, cancer, neurological diseases, cognitive disorders, and psychiatric illnesses; all with a history of alcoholism; smoking; those who are constantly using corticosteroids (injectable/oral) or anticonvulsants; and all who are unable to complete all stages of the study

Design outcomes

Primary

MeasureTime frame
Primary Outcome – It is expected to find an improvement in functional performance, assessed by a functionality questionnaire, with an increase of at least 20% in functional performance. Data will be collected one week before the intervention, two weeks after the intervention, four weeks after the intervention, and during the follow-up

Secondary

MeasureTime frame
Secondary Outcome – It is expected to observe a reduction in pain reported by the patient, measured using the numeric rating scale; an increase in pain threshold by at least 5 kgf, measured through algometry; an increase in muscle strength by at least 5 kgf, measured using dynamometry; and an increase in range of motion by at least 5 degrees, measured through goniometry. Data will be collected one week before the intervention, two weeks after the intervention, four weeks after the intervention, and during the follow-up

Countries

Brazil

Contacts

Public ContactFlávio

Fundação Universidade Federal de Sergipe

flaviomartinsfilho@academico.ufs.br+55 (79) 99627-4702

Outcome results

None listed

Source: REBEC (via WHO ICTRP)